CD8A and neoplasm: In patients in this study for whom tumor-infiltrating immune cells were evaluated in hepatic metastatic tissues, two patients had a notable increase in CD8+ T cells as compared to baseline upon initiation of single-agent therapy (A-2 and S-2).